Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
33.94
-1.46 (-4.12%)
Nov 21, 2024, 4:00 PM EST - Market closed

Ionis Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
5,3597,2585,3654,2977,9068,497
Upgrade
Market Cap Growth
-2.94%35.28%24.86%-45.65%-6.97%14.26%
Upgrade
Enterprise Value
5,0936,9914,6313,6066,6157,112
Upgrade
Last Close Price
35.4050.5937.7730.4356.5460.41
Upgrade
PE Ratio
-----31.80
Upgrade
Forward PE
-----43.66
Upgrade
PS Ratio
6.439.229.135.3010.847.57
Upgrade
PB Ratio
8.4318.779.375.5710.645.04
Upgrade
P/TBV Ratio
9.5318.779.375.5711.055.88
Upgrade
P/FCF Ratio
---228.0310240.4127.00
Upgrade
P/OCF Ratio
---139.52220.2624.59
Upgrade
PEG Ratio
-----0.89
Upgrade
EV/Sales Ratio
6.348.887.884.459.076.34
Upgrade
EV/EBITDA Ratio
-----18.59
Upgrade
EV/EBIT Ratio
-----19.32
Upgrade
EV/FCF Ratio
---191.388569.0022.60
Upgrade
Debt / Equity Ratio
3.015.092.391.621.260.47
Upgrade
Debt / EBITDA Ratio
-----2.04
Upgrade
Debt / FCF Ratio
---66.391217.152.50
Upgrade
Asset Turnover
0.270.290.230.320.260.38
Upgrade
Inventory Turnover
33.9535.9536.0927.8627.1634.96
Upgrade
Quick Ratio
8.245.436.499.133.309.42
Upgrade
Current Ratio
8.915.907.079.753.569.97
Upgrade
Return on Equity (ROE)
-73.38%-76.34%-40.12%-3.78%-39.52%20.01%
Upgrade
Return on Assets (ROA)
-7.25%-7.51%-9.92%-0.69%-3.78%7.80%
Upgrade
Return on Capital (ROIC)
-8.81%-9.66%-12.87%-0.93%-5.12%10.69%
Upgrade
Earnings Yield
-6.54%-5.05%-5.03%-0.67%-5.62%3.27%
Upgrade
FCF Yield
-6.76%-4.56%-5.41%0.44%0.01%3.70%
Upgrade
Buyback Yield / Dilution
-2.19%-0.95%-0.59%-1.01%8.85%-14.25%
Upgrade
Total Shareholder Return
-2.19%-0.95%-0.59%-1.01%8.85%-14.25%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.